
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
,25-Dihydroxyvitamin D3 and 9-cis-Retinoic Acid Directly Inhibits Human Telomerase Reverse Transcriptase Transcription in Prostate Cancer Cells
Department of Urology, Graduate School of Medicine, Yokohama City University, Kanagawa 236-0004, Japan [N. I., H. U., H. I., M. Hos., Y. K.]; Department of Oral Pathology, Kanagawa Dental College, Kanagawa 238-8580, Japan [M. Hor.]; Department of Obstetrics and Gynecology, School of Medicine, Kanazawa University, Ishikawa 920-8641, Japan [S. K.]; and Departments of Nutritional Science [K-i. M.] and Clinical Nutrition [E. T.], School of Medicine, Tokushima University, Tokushima 770-8503, Japan
1 To whom requests for reprints should be addressed, at Department of Urology, School of Medicine, Yokohama City University, Fukuura 3-9, Kanazawa-ku, Yokohama, Kanagawa 236-0004, Japan. E-mail: hu0428{at}med.yokohama-cu.ac.jp
The vitamin D3 receptor, which is the nuclear receptor for 1
,25-dihydroxyvitamin D3 (VD3), forms a heterodimer with the retinoid X receptor (RXR), which is the nuclear receptor for 9-cis-retinoic acid (9-cis-RA). The heterodimer binds to a specific response element consisting of two directly repeated pairs of motifs, AGGTGA, spaced by three nucleotides [direct repeat (DR) 3] and modulates the expression of VD3-responsive genes. Telomerase activity, which is seen in most immortal cells and germ cells, is a complex of enzymes that maintain the length of telomeres. One of the major components of human telomerase, human telomerase reverse transcriptase (hTERT), is the catalytic subunit, and the expression of hTERT might correlate most strongly with telomerase activity. We found that the sequence of 5'-AGTTCATGGAGTTCA-3' (DR3') is similar to that of DR3 in the promoter region of hTERT. Our results showed that the combination of VD3 and 9-cis-RA inhibited telomerase activity through direct interaction of the heterodimer of vitamin D3 receptor and RXR with the DR3' sequence in the hTERT promoter as well as the combination of VD3 and selective RXR ligand did. Also, in vivo data showed that the growth of xenografts in nude mice was inhibited by VD3 and 9-cis-RA. The results of the present study provide evidence on the molecular mechanism of the inhibition of cell growth by these agents, and they could be novel therapeutic agents for prostate cancer.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |